The importance of shedding of membrane proteins for cytokine biology

European Cytokine Network

Volumn 11, Issue 1, 2000, Pages 27-37

  Müllberg, Jürgen ^a   Althoff, Katja ^a   Jostock, Thomas ^a   Rose John, Stefan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

ADAM family; Cytokine; Cytokine receptor; Shedding; TACE

Indexed keywords

CYTOKINE; MEMBRANE PROTEIN; METALLOPROTEINASE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

HOMEOSTASIS; MOLECULAR CLONING; PROTEIN DEGRADATION; PROTEIN FAMILY; REVIEW;

ADAM PROTEINS; ANIMALS; CYTOKINES; HOMEOSTASIS; HUMANS; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; RECEPTORS, CYTOKINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034020230     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. 1. Ehlers M R, Riordan J F. 1991. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry 30: 10065.
2. 2. Rose-John S, Heinrich PC. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300: 281.
3. 3. Hooper N M, Karran E H, Turner A J. 1997. Membrane protein secretases. Biochem. J. 321: 265.
4. 4. Massague J, Pandiella A. 1993. Membrane-anchored growth factors. Annu. Rev. Biochem. 62: 515.
5. 5. Heaney M L, Golde D W. 1996. Soluble cytokine receptors. Blood 87: 847.
6. 6. Müllberg J, Schooltink H, Stoyan T, Heinrich P C, Rose-John S. 1992. Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. Biochem. Biophys. Res. Commun. 189: 794.
7. 7. Müllberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich P C, Rose-John S. 1993. The soluble interleukin-6 receptor is generated by shedding. Em: J. Immunol. 23: 473.
8. 8. Walev I, Vollmer P, Palmer M, Bhakdi S, Rose-John S. 1996. Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 93: 7882.
9. 9. Jones S A, Novick D, Horiuchi S, Yamamoto N, Szalai A J, Fuller G M. 1999. C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J. Exp. Med. 189: 599.
10. 10. Mohler K M, Sleath P R, Fitzner J N, Cerretti D P, Alderson M, Kerwar S S, Torrance D S, Otten Evans C, Greenstreet T, Weerawarna K, Kronheim S R, Petersen M, Gerhart M, Kozlosky C J, March C J, Black R A. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370: 218.
11. 11. Gearing A J, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson A H, Drummond A H, Galloway W A, Gilbert R, Gordon J L, Leber T M, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood L M, Woolley K. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370: 555.
12. 12. McGeehan G M, Becherer J D, Bast Jr R C, Boyer C M, Champion B, Connolly K M, Conway J G, Furdon P, Karp S, Kidao S, McElroy A B, Nichols J, Pryzwanszky M, Schoenen F, Sedut L, Truesdale A, Verghese M, Warner J, Ways J P. 1994. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370: 558.
13. 13. Müllberg J, Rauch C T, Wolfson M F, Castner B, Fitzner J N, Otten Evans C, Mohler K M, Cosman D, Black R A. 1997. Further evidence for a common mechanism for shedding of cell surface proteins. FEBS Lett. 401: 235.
14. 14. Aggarwal B B, Kohr W J, Hass P E, Moffat B, Spencer S A, Henzel W J, Bringman T S, Nedwin G E, Goeddel D V, Harkins R N. 1985. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260: 2345.
15. 15. Black R A, Durie F H, Otten Evans C, Miller R, Slack J L, Lynch D H, Castner B, Mohler K M, Gerhart M, Johnson R S, Itoh Y, Okada Y, Nagase H. 1996. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem. Biophvs. Res. Commun. 225: 400.
16. 16. Black R A, Rauch C T, Kozlosky C J, Peschon J J, Slack J L, Wolfson M F, Castner B J, Stocking K L, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley K A, Gerhart M, Davis R, Fitzner J N, Johnson R S, Paxton R J, March C J, Cerretti D P. 1997. A metalloproteinase disintegrin that releases tumournecrosis factor-α from cells. Nature 385: 729.
17. 17. Stöcker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth F X, McKay D B, Bode W. 1995. The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4: 823.
18. 18. Moss M L, Jin S L, Milla M E, Bickett D M, Burkhart W, Carter H L, Chen W J, Clay W C, Didsbury J R, Hassler D, Hoffman C R, Kost T A, Lambert M H, Leesnitzer M A, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton L K, Schoenen F, Seaton T, Su J L, Warner J, Willard D, Becherer J D. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385: 733.
19. 19. Wolfsberg T G, Primakoff P, Myles D G, White J M. 1995. ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 131: 275.
20. 20. Black R A, White J M. 1998. ADAMs: focus on the protease domain. Curr. Opin. Cell Biol. 10: 654.
21. 21. Gomis-Ruth F X, Meyer E F, Kress L F, Politi V. 1998. Structures of adamalysin II with peptidic inhibitors. Implications for the design of tumor necrosis factor-α convertase inhibitors. Protein Sci. 7: 283.
22. 22. Barr P J. 1991. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66: 1.
23. 23. Maskos K, Fernandez Catalan C, Huber R, Bourenkov G P, Bartunik H, Ellestad G A, Reddy P, Wolfson M F, Rauch C T, Castner B J, Davis R, Clarke H R, Petersen M, Fitzner J N, Cerretti D P, March C J, Paxton R J, Black R A, Bode W. 1998. Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme. Proc. Natl. Acad. Sci. USA 95: 3408.
24. 24. Cerretti D P, DuBose R F, Black R A, Nelson N. 1999. Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression. Biochem. Biophys. Res. Commun. 263: 810.
25. 25. Chantry A, Gregson N A, Glynn P. 1989. A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization. J. Biol. Chem. 264: 21603.
26. 26. Howard L, Lu X, Mitchell S, Griffiths S, Glynn P. 1996. Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types. Biochem. J. 317: 45.
27. 27. Rosendahl M S, Ko S C, Long D L, Brewer M T, Rosenzweig B, Hedl E, Anderoen L, Pyle S M, Moreland J, Meyers M A, Kohno T, Lyons D, Lichenstein H S. 1997. Identification and characterization of a pro-tumor necrosis factor-α-processing enzyme from the ADAM family of zinc metalloproteases. J. Biol. Chem. 272: 24588.
28. 28. Lunn C A, Fan X, Dalie B, Miller K, Zavodny P J, Narula S K, Lundell D. 1997. Purification of ADAM 10 from bovine spleen as a TNF-α convertase. FEBS Lett. 400: 333.
29. 29. Peschon J J, Slack J L, Reddy P, Stocking K L, Sunnarborg S W, Lee D C, Russell W E, Castner B J, Johnson R S, Fitzner J N, Boyce R W, Nelson N, Kozlosky C J, Wolfson M F, Rauch C T, Cerretti D P, Paxton R J, March C J, Black R A. 1998. An essential role for ectodomain shedding in mammalian development. Science 282: 1281.
30. 30. Vollmer P, Walev I, Rose-John S, Bhakdi S. 1996. Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. Infect. Immun. 64: 3646.
31. 31. Wolfsberg T G , White J M. 1996. ADAMs in fertilization and development. Dev. Biol. 180: 389.
32. 32. Blobel C P. 1997. Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNF-α and Notch. Cell 90: 589.
33. 33. Pan D, Rubin G M. 1997. Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90: 271.
34. 34. Qi H, Rand M D, Wu X, Sestan N, Wang W, Rakic P, Xu T, Artavanis-Tsakonas S. 1999. Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science 283: 91.
35. 35. Zolkiewska A. 1999. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain. Exp Cell Res. 252: 423.
36. 36. Jones E Y, Stuart D I, Walker N P. 1989. Structure of tumour necrosis factor. Nature 338: 225.
37. 37. Zhang X P, Kamata T, Yokoyama K, Puzon-McLaughlin W, Takada Y. 1998. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin ανβ3. J. Biol. Chem. 273: 7345.
38. 38. Arribas J, Lopez-Casillas F, Massague J. 1997. Role of the juxtamembrane domains of the transforming growth factor-α precursor and the β-amyloid precursor protein in regulated ecto-domain shedding. J. Biol. Chem. 272: 17160.
39. 39. Sadhukhan R, Sen G C, Ramchandran R, Sen I. 1998. The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface. Proc. Natl. Acad. Sci. USA 95: 138.
40. 40. Kahn J, Walcheck B, Migaki G I, Jutila M A, Kishimoto T K. 1998. Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell 92: 809.
41. 41. Nelson K K, Schlondorff J, Blobel C P. 1999. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor α convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2β. Biochem. J. 343: 673.
42. 42. Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S, Mekada E. 1998. A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKC5 are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17: 7260.
43. 43. Gechtman Z, Alonso J L A, Raab G, Ingber D E, Klagsbrun M. 1999. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/Mitogen-Activated Protein Kinase cascade and by cell adhesion and spreading. J. Biol. Chem. 274: 28828.
44. 44. Bhakdi S, Tranum-Jensen J. 1987. Damage to mammalian cells by proteins that form transmembrane pores. Rev. Physiol. Biochem. Pharmacol. 107: 147.
45. 45. Bhakdi S, Bayley H, Valeva A, Walev I, Walker B, Kehoe M, Palmer M. 1996. Staphylococcal α-toxin, streptolysin O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch. Microbiol. 165: 73.
46. 46. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfitzenmaier K, Scheurich P. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793.
47. 47. Alexopoulou L, Pasparakis M, Kollias G. 1997. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur. J. Immunol 27: 2588.
48. 48. Grell M, Zimmermann G, Gottfried E, Chen C M, Grunwald U, Huang D C, Wu Lee Y H, Dürkop H, Engelmann H, Scheurich P, Wajant H, Strasser A. 1999. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18: 3034.
49. 49. Eugster H P, Muller M, Karrer U, Car B D, Schnyder B, Eng V M, Woerly G, Le Hir M, di Padova F, Aguet M, Zinkernagel R, Bluethmann H, Ryffel B. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol. 8: 23.
50. 50. Luetteke N C, Qiu T H, Peiffer R L, Oliver P, Smithies O, Lee D C. 1993. TGF-α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73: 263.
51. 51. Mann G B, Fowler K J, Gabriel A, Nice E C, Williams R L, Dunn A R. 1993. Mice with a null mutation of the TGF-α gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73: 249.
52. 52. Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, Boraschi D, Martin M U. 1998. The type II 1L-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161: 6871.
53. 53. Orlando S, Sironi M, Bianchi G, Drummond A H, Boraschi D, Yabes D, Mantovani A. 1997. Role of metalloproteases in the release of the IL-1 type II decoy receptor. J. Biol. Chem. 272: 31764.
54. 54. Symons J A, Young P R, Duff G W. 1995. Soluble type II interleukin-1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 92: 1714.
55. 55. Bank U, Reinhold D, Schneemilch C, Kunz D, Synowitz H J, Ansorge S. 1999. Selective proteolytic cleavage of 1L-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. J. Interferon Cytokine Res. 19: 1277.
56. 56. Fernandez-Botran R. 1991. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 5: 2567.
57. 57. Fernandez-Botran R, Vitetta E S. 1991. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J. Exp. Med. 174: 673.
58. 58. Sui X, Tsuji K, Tanaka R, Tajima S, Muraoka K, Ebihara Y, Ikebuchi K, Yasukawa K, Taga T, Kishimoto T, Nakahata T. 1995. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 92: 2859.
59. 59. Peters M, Schirmacher P, Goldschmitt J, Odenthal M, Peschel C, Dienes H P, Fattori E, Ciliberto G, Meyer zum Büschenfelde K H, Rose-John S. 1997. Extramedullary expansion of hematopoietic progenitor cells in IL-6/sIL-6R double transgenic mice. J. Exp. Med. 185: 755.
60. 60. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A. 1997. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6: 315.
61. 61. Klouche M, Bhakdi S, Hemmes M, Rose-John S. 1999. Novel path of activation of primary human smooth muscle cells: upregulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. J. Immunol. 163: 4583.
62. 62. März P, otten U, Rose-John S. 1999. Neuronal activities of IL-6 type cytokines often depend on soluble cytokine receptors. Eur. J. Neurosci. 11: 2995.
63. 63. März P, Cheng J-C, Gadient R A, Patterson P, Stoyan T, Otten U, Rose-John S. 1998. Sympathetic neurons can produce and respond to interleukin-6. Proc. Natl. Acad. Sci. USA 95: 3251.
64. 64. Fischer M, Goldschmitt J, Peschel C, Kallen K J, Brakenhoff J P J, Wollmer A, Grötzinger J, Rose-John S. 1997. A designer cytokine with high activity on human hematopoietic progenitor cells. Nature Biotechnol. 15: 142.
65. 65. Boraschi D, Cifone M G, Falk W, Flad H D, Tagliabue A, Martin M U. 1998. Cytokines in inflammation. Joint Workshop of the Deutsche Gesellschaft für Immunologie and the Gruppo di Cooperazione in Immunologia. Eur. Cytokine Netw. 9: 205.
66. 66. Walchek B, Kahn J, Fisher J M, Wang B B, Fisk R S, Payan D G, Feehan C, Betageri R, Darlak K, Spatola S F, Kishimoto T K. 1996. Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380: 720.
67. 67. Müllberg J, Oberthur W, Lottspeich F, Mehl E, Dittrich E, Graeve L, Heinrich P C, Rose-John S. 1994. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J. Immunol. 152: 4958.
68. 68. Müllberg J, Durie F H, Otten Evans C, Alderson M R, Rose-John S, Cosman D, Black R A, Mohler K M. 1995. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J. Immunol. 155: 5198.
69. 69. Arribas J, Coodly L, Vollmer P, Kishimoto T K, Rose-John S, Massague J. 1996. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271: 11376.
70. 70. Himmler A, Maurer-Fogy I, Kronke M, Scheurich P, Pfizenmaier K, Lantz M, Olsson I, Hauptmann R, Stratowa C, Adolf G R. 1990. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. DNA Cell Biol. 9: 705.
71. 71. Crowe P D, Walter B N, Mohler K M, Otten Evans C, Black R A, Ware C F. 1995. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181: 1205.
72. 72. Migaki G I, Kahn J, Kishimoto T K. 1995. Mutational analysis of the membrane-proximal cleavage site of L-selectin: relaxed sequence specificity surrounding the cleavage site. J. Exp. Med. 182: 549.
73. 73. Higaki J, Quon D, Zhong Z, Cordell B. 1995. Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron 14: 651.
74. 74. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F. 1999. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96: 3922.
75. 75. Ehlers M R, Schwager S L, Scholle R R, Manji G A, Brandt W F, Riordan J F. 1996. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxta-membrane stalk sequence. Biochemistry 35: 9549.
76. 76. Huang E, Nocka K, Beier D R, Chu T Y, Buck J, Lahm H W, Wellner D, Leder P, Besmer P. 1990. The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63: 225.
77. 77. Derynck R, Roberts A B, Winkler M E, Chen E Y, Goeddel D V. 1984. Human transforming growth factor-α: precursor structure and expression in E. coli. Cell 38: 287.
78. 78. Tanaka M, Itai T, Adachi M, Nagata S. 1998. Downregulation of Fas ligand by shedding. Nature Med. 4: 31.
79. 79. Kojro E, Fahrenholz F. 1995. Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase. J. Biol. Chem. 270: 6476.
80. 80. Arribas J, Massague J. 1995. Transforming growth factor-α and β-amyloid precursor protein share a secretory mechanism. J. Cell Biol. 124: 433.
81. 81. Merlos-Suarez A, Fernandez-Larrea J, Reddy P, Baselga J, Arribas J. 1998. Pro-tumor necrosis factor-α processing activity is tightly controlled by a component that does not affect notch processing. J. Biol. Chem. 273: 24955.